We are excited to announce that Inc. magazine notified us that our company, Amuza Inc has made the Inc. 5000 list for the second year in a row. Making us one of the fastest growing companies in the U.S., again!
Last year we were #4679, this year we are #3979 on the list with an 82% growth over the last 3 years. Once more we thank all of our customers, partners and employees for helping us achieve this goal. Our mission is to improve the quality of human lives, and we do this by providing instruments and support to our customers to help them focus on what matters, their research.
Eicom USA has operated under Amuza Inc. since 2012, it isn’t until recent that we decided to go by Amuza. The only change is in the name.
This allows us to provide you with more products that could have a great impact on your research. We are still providing and supporting Eicom products. As well as Amuza’s own brand of neuroscience products to complement those of Eicom. Including innovative microdialysis fraction collectors and rotating cage stages.
We are working hard to improve your experience and provide you with excellent support.
Please feel free to contact us at any time for your technical questions, price quotes, suggestions or complaints to our business. We love to hear from you.
The Amuza Team
Inc. Magazine has been recognizing the fastest growing private companies in America every year since 1982. This year marks their 37th annual Inc. 5000 list.
The 2018 list features Amuza Inc. at No. 4679 with a three year growth of 67%. We are honored to be part of the Inc. 5000 list, it is a great achievement. We want to thank all of our customers, partners and employees as we couldn’t have accomplished this milestone without your loyalty and support.
Amuza Inc. will continue to create and provide innovative research instruments for the life science researchers, along with our dedicated support and partnership.
I would like to take this opportunity to offer our gratitude. Thank you for doing business with Eicom. We at Eicom USA have been providing HPLC-ECD and microdialysis systems for about 15 years to researchers in the US who are at the frontier of neuroscience.
Now we are shifting our company name from Eicom USA to Amuza Inc without changing all of our effort to support our customers by current associates without changing company entity*. You may have heard the name, but now we have made it official to use Amuza as our company name while continuing to provide Eicom products. Amuza has also launched its own brand of neuroscience products to complement those of Eicom, including innovative microdialysis fraction collectors and rotating cage stages. You will enjoy those high standard microdialysis equipment.
Please feel free to contact us at any time for your technical questions, price quotes, suggestions or complaints to our business. I love to talk with our customers and learn from your words.
In addition, we always appreciate your word of mouth. If you know someone who might be interested in our products, please let them know about Eicom or Amuza.
Again, thank you for your business with us.
*PS. We believe you do not need to change our company information in your procurement system because our company identity number (EIN) has not changed. It means you can still place order with our account, with either Eicom or Amuza in your system. Thank you.
We are excited to announce that Amuza Inc have been awarded an R41 Technology Transfer grant by the National Institute of Neurological Disorders (NINDS/NIH, USA) to develop “a unified system of wireless optogenetics and brain microdialysis”. The grant proposal was based on research which combined Amuza’s HPLC-ECD, microdialysis, and optogenetics instruments.
The funding is for Phase I (prototype development and validation) of a Small Business Technology Transfer (STTR) project in collaboration with Drs. Nobuyoshi Suto (The Scripps Research Institute), Thomas Jhou (Medical University of South Carolina) and Matthew Buczynski (Virginia Tech).
After research and commercialization phases have been completed the final opto-dialysis system will be available from Amuza as well. We are currently undertaking the pilot experiments in freely moving animals (both rats and mice) using our opto-dialysis prototypes. We will post the results as they become available. Please stay tuned!